A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)

Clinical trial NCT01226901 · TERMINATED

Trial details

NCT number: NCT01226901
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Solid Tumors

Start date: 2010-11-01
Primary completion: 2011-02-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.